| Parameter | AML group (with CD155 < 5.35) (N = 50) | AML group (with CD155 > 5.35) (N = 50) | P | |||
| Age* | Mean ± SD | 52.94 ± 12.84 | 54.94 ± 15.69 | 0.487 | ||
| Sex | Male | 26 | 52.0% | 28 | 56.0% | 0.688 |
| Female | 24 | 48.0% | 22 | 44.0% | ||
| Hepatomegaly | Positive | 10 | 20.0% | 7 | 14.0% | 0.424 |
| Splenomegaly | Positive | 19 | 38.0% | 24 | 48.0% | 0.313 |
| Lymphadenopathy | Positive | 6 | 12.0% | 6 | 12.0% | 1.00 |
| FAB | M1-M2 | 19 | 38.0% | 23 | 46.0% | 0.175 |
| M3 | 12 | 24.0% | 5 | 10.0% | ||
| M4-M5 | 19 | 38.0% | 22 | 44.0% | ||